Crinetics Pharmaceuticals (CRNX) News Today $29.74 -0.06 (-0.18%) As of 09:39 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRNX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep PipelineJune 30, 2025 | globenewswire.comBrokerages Set Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) PT at $74.56June 30, 2025 | americanbankingnews.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by AnalystsJune 27, 2025 | marketbeat.comCrinetics Pharmaceuticals (NASDAQ:CRNX) Earns Buy Rating from HC WainwrightJune 27, 2025 | marketbeat.comStephen F. Betz Sells 97,483 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) StockJune 17, 2025 | insidertrades.comInsider Selling: Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Sells 97,483 Shares of StockJune 16, 2025 | marketbeat.comCrinetics Pharmaceuticals to Host R&D Day on June 26, 2025June 16, 2025 | globenewswire.comCrinetics Pharmaceuticals: Highly Priced Biotech Awaits PDUFA On Acromegaly DrugJune 16, 2025 | seekingalpha.comRhumbline Advisers Increases Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)June 14, 2025 | marketbeat.comSG Americas Securities LLC Decreases Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)June 11, 2025 | marketbeat.comCrinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 10, 2025 | globenewswire.comAnalysts Offer Predictions for CRNX FY2026 EarningsJune 10, 2025 | marketbeat.comTwo Sigma Advisers LP Sells 14,300 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)June 5, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Purchased by California State Teachers Retirement SystemJune 4, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from BrokeragesJune 2, 2025 | marketbeat.comJane Street Group LLC Sells 122,188 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)June 1, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $17.12 Million in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 31, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 53,529 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 30, 2025 | marketbeat.comWoodline Partners LP Makes New $2.56 Million Investment in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 27, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Position Lessened by D. E. Shaw & Co. Inc.May 27, 2025 | marketbeat.comNuveen Asset Management LLC Boosts Stock Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 25, 2025 | marketbeat.comBank of America Corp DE Decreases Stock Holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 25, 2025 | marketbeat.comProShare Advisors LLC Acquires 9,655 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 24, 2025 | marketbeat.comCrinetics Pharmaceuticals’ SWOT analysis: oral endocrine drug stock poised for growthMay 23, 2025 | investing.comCrinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025May 23, 2025 | globenewswire.com85,000 Shares in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Purchased by Soleus Capital Management L.P.May 21, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Sold by Rafferty Asset Management LLCMay 21, 2025 | marketbeat.comTema Etfs LLC Takes Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 20, 2025 | marketbeat.comAmeriprise Financial Inc. Purchases 186,681 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 18, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Acquired by Point72 Asset Management L.P.May 17, 2025 | marketbeat.comMPM Bioimpact LLC Purchases 91,190 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 16, 2025 | marketbeat.comParkman Healthcare Partners LLC Reduces Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 16, 2025 | marketbeat.comParadigm Biocapital Advisors LP Sells 605,925 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 16, 2025 | marketbeat.comCantor Fitzgerald Weighs in on CRNX FY2025 EarningsMay 16, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Holdings Lifted by Nicholas Investment Partners LPMay 16, 2025 | marketbeat.comCrinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025May 15, 2025 | globenewswire.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Sold by Orbimed Advisors LLCMay 15, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Purchased by Janus Henderson Group PLCMay 15, 2025 | marketbeat.comEnsign Peak Advisors Inc Sells 114,147 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 13, 2025 | marketbeat.comCrinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 12, 2025 | finance.yahoo.comCrinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 12, 2025 | globenewswire.comBrevan Howard Capital Management LP Takes $500,000 Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 12, 2025 | marketbeat.comAlgert Global LLC Lowers Holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 12, 2025 | marketbeat.comFarallon Capital Management LLC Boosts Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 11, 2025 | marketbeat.comNorthern Trust Corp Has $44.99 Million Stock Holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)May 11, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comCrinetics Pharmaceuticals, Inc (CRNX) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Stake Increased by Driehaus Capital Management LLCMay 10, 2025 | marketbeat.comCrinetics Pharmaceuticals (NASDAQ:CRNX) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.May 10, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMay 10, 2025 | marketbeat.com Get Crinetics Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRNX and its competitors with MarketBeat's FREE daily newsletter. Email Address CRNX Media Mentions By Week CRNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRNX News Sentiment▼0.000.58▲Average Medical News Sentiment CRNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRNX Articles This Week▼16▲CRNX Articles Average Week Get Crinetics Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Qiagen News Today Moderna News Today Ascendis Pharma A/S News Today Viatris News Today Blueprint Medicines News Today BridgeBio Pharma News Today Verona Pharma PLC American Depositary Share News Today Roivant Sciences News Today Elanco Animal Health News Today Revolution Medicines News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRNX) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRNX Stock Alerts